Brain Imaging Study for Memory and Thinking Changes
Part of Brain & nervous system, Mental health clinical trials.
This study tests a new type of brain scan (called [18F]Flortaucipir PET) that may help detect early signs of Alzheimer's disease. Researchers want to make sure the scan is safe and works well in Chinese patients aged 50–85 with normal thinking, mild memory problems, or Alzheimer's disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 50 and 85 years old
- Be able to complete memory and thinking tests reliably
- Have one of three conditions: normal cognition, mild cognitive impairment, or Alzheimer's disease (confirmed by prior brain imaging and MRI)
- Not be pregnant, breastfeeding, or planning to have children within 6 months after the study
- Not have had major surgery in the past month or have surgery planned during the study
- Be able to tolerate PET/MRI scanning and not have metal implants or other scan contraindications
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new PET brain scan that uses a special dye to show amyloid plaques, which are linked to Alzheimer's disease. It may help doctors see if your memory problems are caused by Alzheimer's or something else.
This study uses a special PET scan to take pictures of abnormal tau protein in the brain. It aims to see if the scan results match what is found in brain tissue after death, which could help improve diagnosis of Alzheimer's and related conditions.
This trial tests a new PET imaging agent (18F-XTR006) to see how well it shows brain changes related to Alzheimer's disease. It may help diagnose MCI (mild cognitive impairment) or Alzheimer's earlier by comparing images in healthy people and those with memory problems.
This trial looks for signs of Alzheimer’s disease in the brain by using memory and thinking tests, and related study procedures. It may help researchers find better ways to identify Alzheimer’s-related changes earlier.
This study uses brain scans (PET) to look at changes in the brain that may be related to memory problems or Alzheimer's disease. It aims to improve understanding of the disease and may help develop better treatments.
This study uses a special PET scan to look at a brain protein called PDE4 in people with Alzheimer's disease or mild cognitive impairment. It may help researchers understand how this protein is involved in memory and thinking problems.
Hear when a new MCI trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.